Stocktoria

PETMED EXPRESS INC PETS

Nasdaq · stock · Retail-Drug Stores and Proprietary Stores · website · IPO 2000-04-06 · LEI

PETMED EXPRESS INC financials (annual)

Revenue
$249.2M $273.8M $283.4M $284.1M $309.2M $272.3M $256.6M $281.1M $227.0M $179.0M 2017201820192020202120222023202420252026
Net income
$23.8M $37.3M $37.7M $25.9M $30.6M $18.7M $5.1M -$7.5M -$6.3M -$57.3M 2017201820192020202120222023202420252026
Free cash flow
$36.6M $36.7M $44.5M $36.5M $37.6M $16.7M $22.5M -$194000 -$395000 -$33.0M 2017201820192020202120222023202420252026

Bars are annual figures from 2017 to 2026; red bars are negative (a loss or cash outflow).

MetricFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue$179.0M$227.0M$281.1M$256.6M$272.3M$309.2M$284.1M$283.4M$273.8M$249.2M
Gross profit$50.2M$69.1M$84.8M$76.5M$76.9M$89.9M$81.2M$95.3M$97.8M$79.3M
Operating income-$58.7M-$1.5M-$8.2M$6.1M$24.3M$37.6M$31.0M$46.2M$52.1M$37.5M
Income tax-$73,000$5.7M$1.2M$2.3M$5.5M$8.6M$8.0M$11.4M$16.5M$14.1M
Net income-$57.3M-$6.3M-$7.5M$5.1M$18.7M$30.6M$25.9M$37.7M$37.3M$23.8M
EPS (diluted)$-2.74$-0.30$-0.37$0.25$0.92$1.52$1.29$1.84$1.82$1.17
Operating cash flow-$28.4M$4.7M$4.3M$27.8M$18.5M$40.1M$38.8M$45.1M$37.4M$47.2M
Free cash flow-$33.0M-$395,000-$194,000$22.5M$16.7M$37.6M$36.5M$44.5M$36.7M$36.6M
Cash & equivalents$21.4M$54.7M$55.3M$104.1M$111.1M$118.7M$103.8M$100.5M$77.9M$58.7M
Inventory$13.6M$16.2M$28.6M
Total assets$81.2M$148.7M$169.9M$167.5M$176.3M$187.5M$155.3M$154.4M$134.8M$112.8M
Total liabilities$52.3M$63.6M$73.2M$57.5M$34.1M$46.2M$25.3M$19.7M$19.1M$19.4M
Shareholders' equity$28.9M$85.1M$96.7M$110.0M$123.5M$124.9M$130.0M$134.7M$115.7M$93.4M

Growth · year-over-year · Revenue CAGR -3.6%

MetricFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue growth-21.1%-19.2%+9.5%-5.8%-11.9%+8.8%+0.2%+3.5%+9.9%+6.2%
Net income growth-245.2%-72.5%-38.8%+18.4%-31.5%+1.2%+56.5%+15.8%
EPS growth-248.0%-72.8%-39.5%+17.8%-29.9%+1.1%+55.6%+14.7%
Free cash flow growth-100.9%+34.6%-55.5%+3.0%-17.9%+21.4%+0.2%+3865.3%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2026-03-31. Facts plus Stocktoria's own computed scores — not investment advice.